plozalizumab plevistinag
plozalizumab plevistinag: 1 clinical trial tracked.
plozalizumab plevistinag evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
What is verified about plozalizumab plevistinag, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
An Open-label, Dose Escalation and Expansion, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of TAK-500, a Novel Stimulator of Interferon Genes Agonist, as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Select Locally Advanced or Metastatic Solid Tumors
Primary endpoint: Dose Escalation: Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs)